Literature DB >> 25150161

Tularaemia in Norwegian dogs.

Anne Nordstoga1, Kjell Handeland2, Tone Bjordal Johansen3, Lena Iversen4, Dolores Gavier-Widén5, Roland Mattsson6, Kjersti Wik-Larssen7, Jan Egil Afset8, Rune Næverdal9, Arve Lund2.   

Abstract

We describe tularaemia in a Norwegian dog caused by Francisella tularensis subspecies holarctica. A Hamilton Hound and his owner developed tulaeremia after hunting an infected mountain hare (Lepus timidus). The dog showed signs of lethargy, anorexia and fever during a period two to four days after hunting and thereafter fully recovered. Its antibody titers increased 32-fold from one to three weeks post exposure. Thereafter, the titer declined and leveled off at moderate positive values up to one year after exposure (end of study). This is believed to be the first case report of clinical F. tularensis subspecies holarctica infection in a European dog. In 2011, enormous numbers of Norway lemmings (Lemmus lemmus) occurred in Finnmark, the northernmost county of Norway and many dogs caught and swallowed lemmings. Some of these dogs developed non-specific signs of disease and the owners consulted a veterinary surgeon, who suspected tularaemia. In order to investigate this hypothesis, serum samples from 33 dogs were examined for antibodies to F. tularensis. The dogs were allocated into three groups: Dogs from Finnmark that became sick (Group 1) or remained healthy following contact with lemmings (Group 2), and healthy control dogs from Oslo without known contact with lemmings (Group 3). All the serum samples were analyzed with a tube agglutination assay. Among dogs exposed to lemmings, 10/11 and 3/12 were antibody positive in Group 1 and Group 2, respectively, whereas none of the control dogs (n=10) were positive for antibodies against F. tularensis. These results strongly indicate that the non-specific disease seen in the dogs in Finnmark was linked to F. tularensis infection acquired through contact with lemmings.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dogs; Francisella tularensis subspecies holarctica; Hares; Humans; Lemmings; Tularaemia

Mesh:

Substances:

Year:  2014        PMID: 25150161     DOI: 10.1016/j.vetmic.2014.06.031

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Human tularaemia associated with exposure to domestic dogs-United States, 2006-2016.

Authors:  Natalie A Kwit; Amy Schwartz; Kiersten J Kugeler; Paul S Mead; Christina A Nelson
Journal:  Zoonoses Public Health       Date:  2018-12-16       Impact factor: 2.702

2.  First molecular detection of tick-borne pathogens in dogs from Jiangxi, China.

Authors:  Weiqing Zheng; Mingming Liu; Paul Franck Adjou Moumouni; Xiaoqing Liu; Artemis Efstratiou; Zhanbin Liu; Yangqing Liu; Huiying Tao; Huanping Guo; Guanbo Wang; Yang Gao; Zifen Li; Aaron Edmund Ringo; Charoonluk Jirapattharasate; Haiying Chen; Xuenan Xuan
Journal:  J Vet Med Sci       Date:  2016-11-26       Impact factor: 1.267

Review 3.  Control of Lyme borreliosis and other Ixodes ricinus-borne diseases.

Authors:  Hein Sprong; Tal Azagi; Dieuwertje Hoornstra; Ard M Nijhof; Sarah Knorr; M Ewoud Baarsma; Joppe W Hovius
Journal:  Parasit Vectors       Date:  2018-03-06       Impact factor: 3.876

Review 4.  Phylogenetic Lineages of Francisella tularensis in Animals.

Authors:  Paola Pilo
Journal:  Front Cell Infect Microbiol       Date:  2018-07-31       Impact factor: 5.293

5.  First European report of Francisella tularensis subsp. holarctica isolation from a domestic cat.

Authors:  Sonja Kittl; Thierry Francey; Isabelle Brodard; Francesco C Origgi; Stéphanie Borel; Marie-Pierre Ryser-Degiorgis; Ariane Schweighauser; Joerg Jores
Journal:  Vet Res       Date:  2020-08-31       Impact factor: 3.683

Review 6.  Tularemia: a re-emerging tick-borne infectious disease.

Authors:  Derya Karataş Yeni; Fatih Büyük; Asma Ashraf; M Salah Ud Din Shah
Journal:  Folia Microbiol (Praha)       Date:  2020-09-28       Impact factor: 2.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.